Ciprofol
- Generic Name
- Ciprofol
- Indication
用于消化道内镜检查中的镇静、支气管镜检查中的镇静以及全身麻醉诱导。
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT04142970
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, He Nan, China
A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 267
- Registration Number
- NCT04111159
- Locations
- 🇨🇳
West China Hospital，Sichuan University, Chengdu, China
A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients
Phase 2
Completed
- Conditions
- Induction and Maintenance of General Anesthesia
- Interventions
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 46
- Registration Number
- NCT04048811
- Locations
- 🇨🇳
Peking University First Hospital, Peking, China
Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects.
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 25
- Registration Number
- NCT04037657
A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT04033939
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 13
- Registration Number
- NCT04029766
A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2019-09-13
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 178
- Registration Number
- NCT03808844
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, China
A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT03773835
A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT03773042
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT03758469
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath